GO:0002864 regulation of acute inflammatory response to antigenic stimulus: Immune Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002864 describes any process that modulates the frequency, rate, or extent of an acute inflammatory response triggered by an antigenic stimulus.
• The term is a biological_process ontology node, sitting under regulation of acute inflammatory response and encompassing both positive and negative modulation.
• Key molecular players include cytokines, chemokines, pattern-recognition receptors, and transcription factors such as NF-kB and Ets-2.
• Dysregulation of this process contributes to conditions such as atherosclerosis, acute myocardial infarction, osteoarthritis, and bladder inflammatory disorders.
• Experimental models range from LPS-challenged mice and Staphylococcus aureus LTA-stimulated neutrophils to in vitro osteoarthritis cellular systems.
• CRISPR-based knockout, knock-in, point-mutation, and overexpression models enable causal dissection of regulatory nodes in this pathway.
Description
The Gene Ontology term GO:0002864, regulation of acute inflammatory response to antigenic stimulus, defines any biological process that modulates the frequency, rate, or extent of an acute inflammatory response initiated by an antigenic stimulus. This term captures the regulatory layer that sits above the effector inflammatory response, encompassing both amplification and resolution signals that determine whether inflammation remains protective or becomes pathogenic. Understanding this regulation is central to immunology because acute inflammation is a double-edged sword: it is required for host defense, yet uncontrolled or misdirected responses drive tissue injury in cardiovascular, joint, and mucosal diseases. Research into GO:0002864 spans diverse experimental systems, from endotoxin-challenged macrophages and neutrophils to in vitro osteoarthritis models and in vivo bladder inflammation profiling. The term is therefore a useful organizing concept for studies that seek to identify the molecular brakes and accelerators of antigen-driven acute inflammation.
regulation of acute inflammatory response to antigenic stimulus At A Glance
| GO ID | GO:0002864 |
|---|---|
| GO term | regulation of acute inflammatory response to antigenic stimulus |
| Ontology | biological_process |
| Synonym | none |
| Definition | Any process that modulates the frequency, rate, or extent of an acute inflammatory response to an antigenic stimulus. |
| Major function | Tuning the intensity and duration of antigen-driven acute inflammation |
| Parent terms | regulation of acute inflammatory response; regulation of inflammatory response |
| Related processes | cytokine production, immune cell activation, vascular response, resolution of inflammation |
What Is GO:0002864?
In our own words, GO:0002864 refers to any process that adjusts the strength, duration, or likelihood of an acute inflammatory response that is provoked by an antigenic stimulus. It does not describe the inflammatory response itself, but rather the regulatory inputs that tune it up or down. These regulatory processes can act at the level of immune cell activation, cytokine production, vascular permeability, or resolution programs, and they are essential for matching the intensity of inflammation to the threat.
Why Is regulation of acute inflammatory response to antigenic stimulus Important in Cell Biology?
GO:0002864 is important because the balance between effective host defense and collateral tissue damage is decided by regulatory circuits that act on acute inflammation. When these circuits fail, antigenic stimuli such as bacterial components or modified self-antigens can trigger excessive or persistent inflammation, contributing to diseases including atherosclerosis, myocardial infarction, osteoarthritis, and bladder inflammatory disorders. Conversely, insufficient regulation can impair pathogen clearance. Thus, mapping the regulators within GO:0002864 offers therapeutic targets and biomarkers for a wide range of inflammatory conditions.
• Defines the regulatory layer that determines whether acute inflammation resolves or becomes chronic.
• Relevant to cardiovascular disease, where uncontrolled immune responses after myocardial infarction worsen outcomes.
• Implicated in atherosclerosis through CD40 signaling in vascular cells.
• Contributes to joint pathology, as shown in in vitro osteoarthritis models treated with anti-inflammatory drugs.
• Involved in bladder inflammatory disorders, where gene expression profiling reveals distinct inflammatory signatures.
• Modulated by nutritional and pharmacological interventions, such as anti-inflammatory diets and low-dose anti-inflammatory drugs.
• Influenced by metabolic cofactors like tetrahydrobiopterin, which alters neuroinflammatory responses to LPS.
• Regulated by transcription factors such as Ets-2, which controls heme oxygenase-1 in endotoxin responses.
• Trained immunity-like effects in neutrophils can shape subsequent responses to Gram-positive bacterial stimuli.
• Provides a framework for CRISPR-based functional genomics of inflammatory regulators.
What Happens During regulation of acute inflammatory response to antigenic stimulus?
Antigen recognition and initial trigger
In simple terms: The process starts when the immune system detects an antigen, such as a bacterial component or a modified self-molecule.
Antigenic stimuli, including endotoxin (LPS) and lipoteichoic acid (LTA) from Gram-positive bacteria, are recognized by pattern-recognition receptors on innate immune cells. This recognition initiates signaling cascades that will be subject to regulation. For example, Staphylococcus aureus LTA promotes distinct memory-like effects in murine bone marrow neutrophils, indicating that the initial trigger can program subsequent responses. The regulatory processes within GO:0002864 act from this earliest point to set the threshold and magnitude of the response.
Amplification and cytokine/chemokine production
In simple terms: Once triggered, immune cells release signals that recruit more cells and amplify inflammation.
Activated immune cells produce pro-inflammatory cytokines and chemokines that recruit additional leukocytes and amplify the response. This amplification step is a key target of regulation; for instance, Ets-2 regulates heme oxygenase-1 in response to endotoxin, modulating the inflammatory milieu. In bladder inflammatory disorders, gene expression profiling has revealed distinct patterns of inflammatory mediators that reflect active amplification. The extent of amplification determines whether the response remains local and protective or becomes systemic and harmful.
Vascular and tissue responses
In simple terms: Blood vessels and local tissues change to allow immune cells to enter and fight the stimulus.
Acute inflammation involves vascular dilation, increased permeability, and endothelial activation, which are themselves regulated processes. CD40 signaling in vascular cells plays a key role in atherosclerosis, illustrating how vascular regulation of inflammation contributes to disease. In acute myocardial infarction, an uncontrolled immune response can exacerbate tissue damage, highlighting the importance of regulatory checkpoints in the vasculature. These vascular events are integral to the acute inflammatory response and its regulation.
Resolution and negative feedback
In simple terms: The body has built-in brakes to stop inflammation once the threat is controlled.
Resolution of acute inflammation is an active process driven by negative feedback loops, anti-inflammatory cytokines, and specialized pro-resolving mediators. Anti-inflammatory diets and low-dose anti-inflammatory drugs can modulate these resolution pathways, as shown in osteoarthritis cellular models. Tetrahydrobiopterin has been shown to modulate the behavioral neuroinflammatory response to an LPS challenge in mice, indicating that metabolic cofactors can influence resolution. Failure of resolution leads to chronic inflammation and tissue damage.
Memory-like effects and long-term modulation
In simple terms: Some immune cells remember past encounters, changing how they respond next time.
Recent evidence indicates that innate immune cells such as neutrophils can exhibit memory-like effects after exposure to Gram-positive bacterial components, altering subsequent responses. This adds a layer of regulation to GO:0002864, where prior antigenic stimuli can set the responsiveness of the system. Such memory-like effects may contribute to variability in inflammatory diseases and should be considered in experimental design. Understanding these long-term modulations is an emerging area within the regulation of acute inflammatory responses.
Key Genes Involved in GO:0002864 regulation of acute inflammatory response to antigenic stimulus
The following genes and proteins have been experimentally linked to the regulation of acute inflammatory responses to antigenic stimuli, as documented in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ETS2 | Transcription factor regulating heme oxygenase-1 in endotoxin response | Modulates inflammatory gene expression in macrophages |
| HMOX1 | Heme oxygenase-1, anti-inflammatory enzyme | Target of Ets-2 regulation; protects against oxidative stress |
| CD40 | Costimulatory receptor on vascular cells | Key role in atherosclerosis and vascular inflammation |
| TNF | Pro-inflammatory cytokine | Central amplifier of acute inflammation; target of regulation |
| IL6 | Pro-inflammatory cytokine | Involved in amplification and resolution phases |
| IL1B | Pro-inflammatory cytokine | Mediates acute inflammatory responses in various tissues |
| NFKB1 | Transcription factor | Master regulator of inflammatory gene expression |
| TLR4 | Pattern-recognition receptor for LPS | Initiates signaling in response to Gram-negative bacteria |
| TLR2 | Pattern-recognition receptor for LTA | Recognizes Gram-positive bacterial components |
| CXCL8 | Chemokine recruiting neutrophils | Amplifies acute inflammation |
| CCL2 | Chemokine recruiting monocytes | Contributes to monocyte infiltration in inflammation |
| PTGS2 | Cyclooxygenase-2, prostaglandin synthesis | Target of anti-inflammatory drugs; modulates inflammation |
| GCH1 | GTP cyclohydrolase 1, tetrahydrobiopterin synthesis | Modulates neuroinflammatory response to LPS |
| NOS2 | Inducible nitric oxide synthase | Produces NO during inflammation; regulated by cofactors |
| VCAM1 | Adhesion molecule on endothelium | Facilitates leukocyte recruitment in vascular inflammation |
| ICAM1 | Adhesion molecule on endothelium | Supports leukocyte adhesion and transmigration |
| MMP9 | Matrix metalloproteinase-9 | Tissue remodeling during inflammation |
| SAA1 | Serum amyloid A1, acute-phase protein | Marker of acute inflammatory response |
How Is regulation of acute inflammatory response to antigenic stimulus Regulated?
The regulation of acute inflammatory response to antigenic stimulus is itself controlled by multiple layers, including transcriptional, post-transcriptional, and metabolic mechanisms. Transcription factors such as NF-kB and Ets-2 drive or dampen inflammatory gene expression. Metabolic cofactors like tetrahydrobiopterin can modulate neuroinflammatory responses to LPS, indicating that the availability of enzyme cofactors influences the regulatory outcome. Anti-inflammatory diets and low-dose anti-inflammatory drugs can shift the balance toward resolution, as demonstrated in osteoarthritis models. Additionally, innate immune memory-like effects in neutrophils can reprogram subsequent responses to antigenic stimuli. These regulatory inputs collectively determine the intensity and duration of acute inflammation.
regulation of acute inflammatory response to antigenic stimulus and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CD40 | Atherosclerosis | ApoE-/- mouse with CD40 knockout or knock-in |
| ETS2 | Endotoxin response and inflammation | Macrophage-specific Ets2 knockout |
| GCH1 | Neuroinflammation | LPS-challenged mice with Gch1 modulation |
| PTGS2 | Osteoarthritis | In vitro chondrocyte model treated with anti-inflammatory drugs |
| TLR2 | Gram-positive bacterial infection | Staphylococcus aureus LTA-stimulated neutrophils |
Atherosclerosis and cardiovascular disease
CD40 signaling in vascular cells plays a key role in atherosclerosis, linking the regulation of acute inflammatory responses to plaque formation and progression. In acute myocardial infarction, an uncontrolled immune response can exacerbate myocardial damage, underscoring the need for tight regulation of antigen-driven inflammation. These findings suggest that targeting regulatory nodes within GO:0002864 could reduce cardiovascular morbidity.
Osteoarthritis and joint inflammation
In vitro osteoarthritis cellular models have been used to study inflammatory response modulation by low-dose anti-inflammatory drugs, highlighting the relevance of GO:0002864 to joint pathology. The regulation of acute inflammation in cartilage and synovium influences disease progression and pain. Anti-inflammatory diets may also modulate these pathways, offering lifestyle-based interventions.
Bladder inflammatory disorders
Gene expression profiling of inflammatory bladder disorders has revealed distinct molecular signatures that reflect dysregulated acute inflammatory responses. These signatures include altered expression of cytokines, chemokines, and matrix metalloproteinases. Understanding the regulatory mechanisms within GO:0002864 may lead to better diagnostics and therapies for bladder inflammation.
Neuroinflammation and behavioral changes
Tetrahydrobiopterin modulates the behavioral neuroinflammatory response to an LPS challenge in mice, demonstrating that metabolic regulators can influence neuroinflammation. This connects GO:0002864 to neurological and psychiatric symptoms associated with systemic inflammation. Further research into these regulatory pathways may uncover targets for neuroinflammatory conditions.
From regulation of acute inflammatory response to antigenic stimulus-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate the magnitude of acute inflammation? | CRISPR knockout in macrophage cell line followed by LPS stimulation |
| Does a specific point mutation in gene Y alter regulatory function? | CRISPR point-mutation knock-in in primary immune cells |
| Does overexpression of gene Z dampen inflammation? | Lentiviral overexpression in endothelial cells |
| Does a tagged version of protein W localize to inflammatory signaling complexes? | CRISPR knock-in of fluorescent tag |
| Does gene V affect neutrophil memory-like responses? | Bone marrow neutrophil adoptive transfer after LTA exposure |
| Does metabolic cofactor availability modulate inflammation? | Tetrahydrobiopterin supplementation in LPS-challenged mice |
How to Study the regulation of acute inflammatory response to antigenic stimulus Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify regulatory genes in inflammatory models |
| ELISA | Cytokine protein levels | Quantify TNF, IL-6, IL-1β after stimulation |
| Flow cytometry | Immune cell phenotype and activation | Assess neutrophil memory-like effects |
| Western blot | Protein expression and signaling activation | Measure NF-kB and Ets-2 activity |
| CRISPR screening | Functional gene identification | Discover regulators of acute inflammation |
| Luminex | Multiplex cytokine profiling | Characterize inflammatory signatures |
| In vivo LPS challenge | Systemic inflammatory response | Test gene function in whole animals |
| Immunohistochemistry | Tissue localization of inflammatory markers | Assess vascular inflammation in atherosclerosis |
Transcriptomic profiling
RNA-seq and microarray analysis can identify global changes in gene expression during the regulation of acute inflammatory responses. For example, gene expression profiling of inflammatory bladder disorders has revealed distinct inflammatory signatures. These methods are useful for discovering novel regulatory genes and pathways.
Cytokine and chemokine quantification
ELISA, Luminex, and cytokine arrays measure the production of inflammatory mediators, providing a quantitative readout of regulatory effects. In osteoarthritis models, such measurements have been used to assess anti-inflammatory drug effects. These assays are essential for validating CRISPR-based perturbations.
Flow cytometry and immune cell phenotyping
Flow cytometry can quantify immune cell activation, recruitment, and memory-like phenotypes. For instance, Staphylococcus aureus LTA promotes distinct memory-like effects in murine bone marrow neutrophils, which can be assessed by flow cytometry. This method helps link regulatory genes to specific immune cell behaviors.
In vivo inflammation models
Animal models such as LPS-challenged mice or myocardial infarction models allow study of systemic inflammatory regulation. These models can be combined with CRISPR-mediated gene editing to test causality. They are critical for translating in vitro findings to whole-organism physiology.
How CRISPR Can Be Used to Study GO:0002864 regulation of acute inflammatory response to antigenic stimulus
Knockout
CRISPR knockout of candidate regulatory genes in immune or vascular cells can determine whether they are necessary for modulating acute inflammatory responses. For example, knocking out Ets2 in macrophages would test its role in endotoxin-induced heme oxygenase-1 regulation. Knockout models are also valuable for validating hits from CRISPR screens.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes to dissect functional domains of regulatory proteins. This is useful for studying phosphorylation sites or catalytic residues in enzymes like GCH1 that influence inflammation. Point-mutation models help distinguish between scaffolding and enzymatic functions.
Knock-in
Knock-in of tags or reporters allows real-time tracking of regulatory proteins during inflammation. For instance, a fluorescent tag on NF-kB could reveal its dynamics in live cells. Knock-in of human disease variants can also model genetic susceptibility to inflammatory diseases.
Overexpression
Overexpression of anti-inflammatory genes or dominant-negative mutants can test whether increasing a regulator's activity dampens acute inflammation. This approach has been used to study CD40 signaling in vascular cells. Overexpression models complement knockout studies by providing gain-of-function evidence.
How EDITGENE Supports regulation of acute inflammatory response to antigenic stimulus Research
Researchers studying regulation of acute inflammatory response to antigenic stimulus-related genes often need to determine whether a candidate gene is causally involved in modulating inflammation or merely correlated with it. CRISPR-based genome editing provides the gold-standard approach for establishing causality, and EDITGENE offers a comprehensive suite of services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for regulation of acute inflammatory response to antigenic stimulus research.
Frequently Asked Questions About regulation of acute inflammatory response to antigenic stimulus
What is GO:0002864?
GO:0002864 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate, or extent of an acute inflammatory response to an antigenic stimulus.
What genes are involved in regulation of acute inflammatory response to antigenic stimulus?
Key genes include ETS2, HMOX1, CD40, TNF, IL6, IL1B, NFKB1, TLR4, TLR2, and GCH1, among others.
How is acute inflammatory response to antigenic stimulus regulated?
It is regulated by transcriptional factors like NF-kB and Ets-2, metabolic cofactors such as tetrahydrobiopterin, and anti-inflammatory mediators that promote resolution.
What diseases are associated with dysregulation of GO:0002864?
Dysregulation is linked to atherosclerosis, acute myocardial infarction, osteoarthritis, bladder inflammatory disorders, and neuroinflammation.
What experimental models are used to study GO:0002864?
Models include LPS-challenged mice, Staphylococcus aureus LTA-stimulated neutrophils, in vitro osteoarthritis cellular systems, and gene expression profiling of bladder inflammation.
How can CRISPR help study regulation of acute inflammatory response to antigenic stimulus?
CRISPR knockout, knock-in, point mutation, and overexpression enable causal testing of candidate regulatory genes in immune and vascular cells.
What is the role of Ets-2 in acute inflammation?
Ets-2 regulates heme oxygenase-1 in response to endotoxin, thereby modulating the inflammatory response.
Does tetrahydrobiopterin affect inflammation?
Yes, tetrahydrobiopterin modulates the behavioral neuroinflammatory response to an LPS challenge in mice.
What is the link between CD40 and atherosclerosis?
CD40 signaling in vascular cells plays a key role in atherosclerosis, influencing inflammatory processes in the vessel wall.
Can anti-inflammatory diets modulate GO:0002864?
Anti-inflammatory diets may modulate inflammatory pathways, as reviewed in the context of regulation of acute inflammatory responses.
Conclusion
GO:0002864, regulation of acute inflammatory response to antigenic stimulus, represents a critical regulatory layer that determines the outcome of antigen-driven inflammation. Its components are implicated in major human diseases, from cardiovascular disorders to osteoarthritis and neuroinflammation. Advances in CRISPR genome editing and functional genomics now allow researchers to dissect these regulatory mechanisms with unprecedented precision. Continued investigation of GO:0002864 will likely yield new therapeutic strategies for inflammatory diseases.
References
- 1. Scheiber A et al.. 2026. Anti-Inflammatory Diets.. PMID: 37983365
- 2. Iuliano M et al.. 2024. Inflammatory Response Modulation by Low-Dose Anti-inflammatory Drugs Treatment in an In Vitro Osteoarthritis Cellular Model.. Curr Med Chem 31(13):1740-1753 PMID: 37032507
- 3. Saban MR et al.. 2003. Gene expression profiling of inflammatory bladder disorders.. Expert Rev Mol Diagn 3(2):217-35 PMID: 12647997
- 4. Bodi V et al.. 2008. Uncontrolled immune response in acute myocardial infarction: unraveling the thread.. Am Heart J 156(6):1065-73 PMID: 19033000
- 5. Vancassel S et al.. 2022. Tetrahydrobiopterin modulates the behavioral neuroinflammatory response to an LPS challenge in mice.. Brain Behav Immun 105:139-148 PMID: 35781010
- 6. Chung SW et al.. 2005. Role of Ets-2 in the regulation of heme oxygenase-1 by endotoxin.. J Biol Chem 280(6):4578-84 PMID: 15590657
- 7. Mach F et al.. 1998. CD40 signaling in vascular cells: a key role in atherosclerosis?. Atherosclerosis 137 Suppl:S89-95 PMID: 9694547
- 8. Lajqi T et al.. 2022. Gram-positive Staphylococcus aureus LTA promotes distinct memory-like effects in murine bone marrow neutrophils.. Cell Immunol 376:104535 PMID: 35537323
